Drug Type Small molecule drug |
Synonyms- |
Target |
Action modulators |
Mechanism Cholesterol modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Meibomian Gland Dysfunction | Phase 2 | United States | 05 Sep 2021 |
Phase 2 | 92 | (CBT-006 Lower Concentration) | vtblpfhexp(lpopddmndp) = zjoeamtxcs pdcvnthmod (tvywtqjwzf, 2.6230) View more | - | 24 Apr 2024 | ||
(CBT-006 Higher Concentration) | vtblpfhexp(lpopddmndp) = wdikzmbuza pdcvnthmod (tvywtqjwzf, 2.6647) View more |